Comparative Effects of Jacobson's Relaxation Techniques and Stretching Exercises in Preeclampsia

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05863962
Collaborator
(none)
28
1
2
7
4

Study Details

Study Description

Brief Summary

To compare the effect of Jacobson's Relaxation Techniques and stretching exercises on Preeclampsia in pregnant women.

Condition or Disease Intervention/Treatment Phase
  • Other: walking and Stretching
  • Other: walking and Jacobsons relaxation technique
N/A

Detailed Description

The effectiveness of Jacobson's progressive muscle relaxation technique on maternal, fetal, and neonatal outcomes in women with non-severe preeclampsiain have been studied in an RCT study. Pregnant women who use this technique experience reduced muscle tension and a sense of calm. in one of the study The Effect of Relaxation Techniques on Blood Pressure and Stress Among Pregnant Women with Mild Pregnancy Induced Hypertension were investigated in which Women with mild pregnancy-induced hypertension who used relaxation techniques saw significant improvements in their knowledge, physiological parameters, and blood pressure as well as a reduction in stress.

To the best of the researcher's knowledge, no comparative study has been done to yet to evaluate the efficacy of relaxation and stretching exercise. There is not enough data to determine whether Jacobson's relaxation techniques and stretching exercise reduce preeclampsia in pregnant women. As a result, this study will contribute to the expanding body of knowledge about which approach should be used as an alternative if results from other procedures are comparable

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparative Effects of Jacobson's Relaxation Techniques and Stretching Exercises on Blood Pressure and Anxiety in Preeclampsia
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stretching Exercises

walking with stretching exercises

Other: walking and Stretching
Stretching exercise will be given for 6 weeks (3 sessions per week). 15 minutes of moderate walking with stretching exercises 5 times a week with Warm up and Cool down. Videos will be provided to participants to follow at home. Participants will be provided forms for home to fill after every session completed and frequency of each exercise

Active Comparator: Jacobson's Technique

walking with Jacobson's Relaxation Technique.

Other: walking and Jacobsons relaxation technique
Jacobson's Relaxation Technique will be given for 6 weeks. 15 minutes of moderate walking with Jacobson's Relaxation Technique. Videos will be provided to participants to follow at home. Participants will be provided forms for home to fill after every session completed. Participants will also bring their Pedometer

Outcome Measures

Primary Outcome Measures

  1. Mercury sphygmomanomete [4 Weeks]

    patient have systolic blood pressure of 140 mm Hg or higher and/or a diastolic blood pressure of 90 mm Hg or higher.

Secondary Outcome Measures

  1. Pregnancy related anxiety questionnaire [4 Weeks]

    The degree of anxiety was estimated using Pregnancy related anxiety Questionnaire assessing the symptoms on scale 1 to 5 . 1 being not relevant and 5 relevant.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gestational age was exceeding 24 weeks

  • BP more than or up to 140/90

  • Diagnosed with gestational Hypertension

  • Primiparous

Exclusion Criteria:
  • Women with history of preterm labor or repeated abortion

  • Bleeding

  • Intra uterine fetal growth anomalies

  • Underlying mental (depression with severe anxiety)

  • Cardio respiratory diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jinnah Hospital Lahore Punjab Pakistan 05499

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Hafiza Mehjabeen, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05863962
Other Study ID Numbers:
  • REC/RCR&AHS/23/0504
First Posted:
May 18, 2023
Last Update Posted:
May 18, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 18, 2023